Digital lens fitting and dispensing technology for tablets

Article

Irving, TX, and Rancho Cordova, CA—PFO Global and VSP Optics Group are co-developing digital lens fitting and dispensing technology for eye-care professionals to use on tablet or mobile computers. Together, the companies have jointly applied for patents on the technology, on which they have been in technical collaboration for the past year.

Irving, TX, and Rancho Cordova, CA-PFO Global and VSP Optics Group are co-developing digital lens fitting and dispensing technology for eye-care professionals to use on tablet or mobile computers. Together, the companies have jointly applied for patents on the technology, on which they have been in technical collaboration for the past year.

“We are thrilled to further develop this breakthrough digital lens measurement and dispensing technology through cutting-edge research and development with VSP Optics Group,” said Rudolf Suter, CEO and president of PFO Global. “Together, we are dedicated to developing technology aimed at improving the eye-care experience for patients and providers alike.”

VSP Optics Group has also signed an agreement with PFO Global for the exclusive distribution rights of the technology.

For more articles in this issue of InDispensable, click here.

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.